Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy. (Q51055812)
Jump to navigation
Jump to search
scientific article published on 21 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy. |
scientific article published on 21 April 2013 |
Statements
Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy. (English)
1 reference
Guohong Song
1 reference
Xiaoli Wang
1 reference
Jun Jia
1 reference
Yanhua Yuan
1 reference
Fengling Wan
1 reference
Xinna Zhou
1 reference
Huabing Yang
1 reference
Jun Ren
1 reference
Jiezhun Gu
1 reference
21 April 2013
1 reference
62
1 reference
6
1 reference
1123-1130
1 reference
Identifiers
1 reference